History
In 1884, researcher Flückiger M. Vorkommen made a significant contribution to the field of medicine by reporting the first cases of hypoxemia in patients with liver disease. His findings included the presence of cyanosis, digital clubbing, and hypoxemia in individuals with chronic liver disease. It wasn’t until 1977, a century later, that two additional researchers identified and named this condition “hepatopulmonary syndrome” based on their examination of a patient displaying these symptoms.
Cause of Hepatopulmonary Syndrome
The cause of hepatopulmonary syndrome remains largely unknown to physicians and researchers. It is still unclear why some individuals with liver disease develop this syndrome while others do not. However, it is understood that liver disease can lead to the dilation of blood vessels in the lungs, which can ultimately result in the failure of oxygen transfer. Ongoing research is primarily focused on understanding why liver disease triggers the dilation of the blood vessels that enter the lungs. One prevailing theory suggests that liver disease inhibits the release of certain factors, consequently impeding the growth of blood vessel cells.